In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more. * Contains 18 relevant, practice-oriented topics including the role of surgery in metastatic renal cell cancer; emerging…mehr
In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more. * Contains 18 relevant, practice-oriented topics including the role of surgery in metastatic renal cell cancer; emerging biomarkers in metastatic renal cell cancer; choosing the right treatment for renal cell cancer of variant histology; novel targets in the treatment of renal cell cancer; and more. * Provides in-depth clinical reviews on renal cell cancer, offering actionable insights for clinical practice. * Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology Immunobiology and Metabolic Pathways of Renal Cell Carcinoma Hereditary Renal Cell Carcinoma Syndromes The Role of the Pathologist in Renal Cell Carcinoma Management Insights into Renal Cell Carcinoma with Novel Imaging Approaches Surgical Management of Localized Disease and Small Renal Masses Role of Surgery in Metastatic Renal Cell Carcinoma Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma Role of Radiation in Treatment of Renal Cell Carcinoma Prognostic Models in Metastatic Renal Cell Carcinoma Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy Renal Cell Carcinoma of Variant Histology: Biology and Therapies Toxicity Management of Systemic Kidney Cancer Therapies Management of Brain Metastases in Metastatic Renal Cell Carcinoma Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology Immunobiology and Metabolic Pathways of Renal Cell Carcinoma Hereditary Renal Cell Carcinoma Syndromes The Role of the Pathologist in Renal Cell Carcinoma Management Insights into Renal Cell Carcinoma with Novel Imaging Approaches Surgical Management of Localized Disease and Small Renal Masses Role of Surgery in Metastatic Renal Cell Carcinoma Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma Role of Radiation in Treatment of Renal Cell Carcinoma Prognostic Models in Metastatic Renal Cell Carcinoma Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy Renal Cell Carcinoma of Variant Histology: Biology and Therapies Toxicity Management of Systemic Kidney Cancer Therapies Management of Brain Metastases in Metastatic Renal Cell Carcinoma Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309